علاج مرض بهجت مع مرض العين الالتهابي المؤثر على الجزء الخلفي

References

DOI: 10.1136/annrheumdis-2018-213225

1. Any patient with BS and inflammatory eye disease affecting the posterior segment should be on a treatment regime such as azathioprine (level of evidence: IB; strength of recommendation: A), cyclosporine-A (level of evidence: IB; strength of recommendation: A), interferon-alpha (level of evidence: IIA; strength of recommendation: B) or monoclonal anti-TNF antibodies (level of evidence: IIA; strength of recommendation: B).
2. Systemic glucocorticoids should be used only in combination with azathioprine or other systemic immunosuppressives.
3. Management of uveitis of BS requires close collaboration with ophthalmologists with the ultimate aim of inducing and maintaining remission.